Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response, Intolerance, or Contraindication to Cyclosporine: Results From a Randomized, Placebo-Controlled, Phase III Clinical Trial (BREEZE-AD4)
Br J Dermatol 2022 Apr 28;[EPub Ahead of Print], T Bieber, K Reich, C Paul, Y Tsunemi, M Augustin, JP Lacour, PD Ghislain, Y Dutronc, R Liao, FE Yang, D Brinker, AM DeLozier, E Meskimen, JM Janes, K EyerichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.